View drug registration information details.
Items | Registration information |
ID | 2305 |
No | 2305 |
Brand Name | EXSIROX |
Ingredients | DEFERASIROX 250 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 4 X 7'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | TREATMENT OF CHRONIC IRON OVERLOAD DUE TO BLOOD TRANSFUSIONS IN ADULT AND PEDIATRIC PATIENTS (AGED 2 YEARS AND OVER). ALSO INDICATED FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA SYNDROMS AGED 10 YEARS AND OLDER |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | ROUND FLAT TABLET WITH BEVELED EDGE, WHITE TO SLIGHTLY YELLOW AND IMPRINTED WITH "BC" AND " 250 " ON ONE SIDE |
Note | |
License Owner | SOKDY OSOTH IMPORT-EXPORT CO., LTD |
Manufacturer | BIOLAB CO.,LTD |
Country | THAILAND |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 I 5087/21 |
FDD Registration Date | 08-APR-2024 |
Expiry Date | 07-APR-2027 |
Back to drug list
|